![N-[(3-endo)-8-{(2S)-2-Hydroxy-3-[4-(methylsulfonyl)-1-piperazinyl ]propyl}-8-azabicyclo[3.2.1]oct-3-yl]-1-isopropyl-2-oxo-1,2-dihyd ro-3-quinolinecarboxamide结构式](https://www.chemsrc.com/caspic/030/886579-13-1.png)
N-[(3-endo)-8-{(2S)-2-Hydroxy-3-[4-(methylsulfonyl)-1-piperazinyl ]propyl}-8-azabicyclo[3.2.1]oct-3-yl]-1-isopropyl-2-oxo-1,2-dihyd ro-3-quinolinecarboxamide结构式
|
常用名 | N-[(3-endo)-8-{(2S)-2-Hydroxy-3-[4-(methylsulfonyl)-1-piperazinyl ]propyl}-8-azabicyclo[3.2.1]oct-3-yl]-1-isopropyl-2-oxo-1,2-dihyd ro-3-quinolinecarboxamide | 英文名 | N-[(3-endo)-8-{(2S)-2-Hydroxy-3-[4-(methylsulfonyl)-1-piperazinyl ]propyl}-8-azabicyclo[3.2.1]oct-3-yl]-1-isopropyl-2-oxo-1,2-dihyd ro-3-quinolinecarboxamide |
|---|---|---|---|---|
| CAS号 | 886579-13-1 | 分子量 | 559.72100 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C28H41N5O5S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-[(3-endo)-8-{(2S)-2-Hydroxy-3-[4-(methylsulfonyl)-1-piperazinyl ]propyl}-8-azabicyclo[3.2.1]oct-3-yl]-1-isopropyl-2-oxo-1,2-dihyd ro-3-quinolinecarboxamide |
|---|
| 分子式 | C28H41N5O5S |
|---|---|
| 分子量 | 559.72100 |
| 精确质量 | 559.28300 |
| PSA | 127.06000 |
| LogP | 2.71500 |
|
~%
N-[(3-endo)-8-{... 886579-13-1 |
| 文献：THERAVANCE, INC. Patent: US2006/100426 A1, 2006 ; Location in patent: Page/Page column 21 ; US 20060100426 A1 |
|
~75%
N-[(3-endo)-8-{... 886579-13-1 |
| 文献：McKinnell, R. Murray; Armstrong, Scott R.; Beattie, David T.; Choi, Seok-Ki; Fatheree, Paul R.; Gendron, Roland A. L.; Goldblum, Adam; Humphrey, Patrick P.; Long, Daniel D.; Marquess, Daniel G.; Shaw; Smith, Jacqueline A. M.; Turner, S. Derek; Vickery, Ross G. Journal of Medicinal Chemistry, 2009 , vol. 52, # 17 p. 5330 - 5343 |
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |
![N-{8-azabicyclo[3.2.1]octan-3-yl}-2-oxo-1-(propan-2-yl)-1,2-dihydroquinoline-3-carboxamide结构式](https://www.chemsrc.com/caspic/384/174486-91-0.png)
![1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-aza-bicyclo[3.2.1]oct-3-yl}amide trifluoroacetate结构式](https://www.chemsrc.com/caspic/449/866777-83-5.png)